Can infliximab serve as a new therapy for neuropsychiatric symptoms?

Saved in:
Bibliographic Details
Title: Can infliximab serve as a new therapy for neuropsychiatric symptoms?
Authors: Rahmati-Dehkordi F; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.; Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Birang N; Department of Physical Medicine and Rehabilitation, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran., Jalalian MN; Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Tamtaji Z; Student Research Committee, Kashan University of Medical Sciences, Kashan, Iran., Dadgostar E; Behavioral Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.; Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran., Aschner M; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA., Shafiee Ardestani M; Department of Radio Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Jafarpour H; Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran., Mirzaei H; Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran. h.mirzaei2002@gmail.com., Nabavizadeh F; Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Nabavizadeh@tums.ac.ir.; Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Nabavizadeh@tums.ac.ir., Tamtaji OR; Electrophysiology Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. tamtaji.or@gmail.com.; Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. tamtaji.or@gmail.com.
Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2025 Feb; Vol. 398 (2), pp. 1081-1097. Date of Electronic Publication: 2024 Sep 03.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1912
DOI:10.1007/s00210-024-03397-w